[Late drug-induced hyperkalemia in a patient with congestive heart failure].
Patients with congestive heart failure are at risk for hiperkaliemia because of coexisting comorbidities and use of multiple medications that impair potassium excretion--such as angiotensin-converting enzyme inhibitors or spironolactone. This is the case report about the patient with late drug-induced hyperkalemia. Causes and prevention methods used against development of this adverse event were explained.
Konopa
Joanna
J
Klinika Nefrologii, Transplantologii i Chorób Wewnetrznych Akademii Medycznej w Gdańsku.
Bułło
Barbara
B
Rutkowski
Bolesław
B
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000188:drug therapy / Q000628:therapy; D006435:Renal Dialysis; D013148:Spironolactone / Q000009:adverse effects; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D004232:Diuretics; D013148:Spironolactone